Telomir Pharmaceuticals, Inc. (TELO) KPIs and segments

TELONasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 6/30

$0.49−0.01 (-1.96%)

Close on Nov 13, 2026Market cap $33.74MP/E –Yield –

KPIs & segments

Operating metrics and segments that drive Telomir Pharmaceuticals's business

Coming soon

This tab will track the numbers specific to Telomir Pharmaceuticals's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?